Investor Presentaiton
Q2 2023 INCOME STATEMENT NOTES
Lilly
Q2 2023 NON-GAAP INFORMATION HAS BEEN ADJUSTED TO EXCLUDE:
amortization of intangibles primarily associated with costs of marketed products acquired or licensed from third parties totaling $126.4 million
(pretax), or $0.11 per share (after-tax); and
net losses on investments in equity securities totaling $53.9 million (pretax), or $0.05 per share (after-tax).
Q2 2022 NON-GAAP INFORMATION HAS BEEN ADJUSTED TO EXCLUDE:
amortization of intangibles primarily associated with costs of marketed products acquired or licensed from third parties totaling $121.3 million
(pretax), or $0.11 per share (after-tax); and
net losses on investments in equity securities totaling $106.3 million (pretax), or $0.09 per share (after-tax).
Not for promotional use
2023 Q2 EARNINGS
26View entire presentation